Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonasexotoxin in patients with metastatic adrenocortical carcinoma

Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993

(2013) Thomas M.A. Kerkhofs et al.   EUROPEAN JOURNAL OF CANCER

Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma

(2012) Meenu Jain et al.   CANCER

Specific Targeting of Human Interleukin (IL)-13 Receptor α2-Positive Cells with Lentiviral Vectors Displaying IL-13

(2012) Wu Ou et al.   Human Gene Therapy Methods

Thrombotic Microangiopathy with Targeted Cancer Agents

(2011) John A. Blake-Haskins et al.   CLINICAL CANCER RESEARCH

Adrenocortical carcinoma: a clinician's update

(2011) Martin Fassnacht et al.   Nature Reviews Endocrinology

Interleukin 13 Mediates Signal Transduction through Interleukin 13 Receptor  2 in Pancreatic Ductal Adenocarcinoma: Role of IL-13 Pseudomonas Exotoxin in Pancreatic Cancer Therapy

(2010) T. Shimamura et al.   CLINICAL CANCER RESEARCH

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma

(2010) S. Kunwar et al.   NEURO-ONCOLOGY

Clinical management of adrenocortical carcinoma

(2009) Martin Fassnacht et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Expression of IL-13Rα2 in liver cancer cells and its effect on targeted therapy of liver cancer

(2009) Lingling Hou et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Adrenocortical carcinoma in the United States

(2008) Karl Y. Bilimoria et al.   CANCER

Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin

(2008) Mitomu Kioi et al.   MOLECULAR CANCER THERAPEUTICS